Lipid-protein interactions, regulation and dysfunction of brain cholesterol

Biochemical and Biophysical Research Communications

Volumn 354, Issue 3, 2007, Pages 627-633

  Chattopadhyay, Amitabha ^a   Paila, Yamuna Devi ^a  

^a CENTRE FOR CELLULAR AND MOLECULAR BIOLOGY   (India)

Author keywords

Brain cholesterol; Lipid protein interaction; Serotonin1A receptor; Smith Lemli Opitz Syndrome

Indexed keywords

CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPOCHOLESTEROLEMIC AGENT; LIPID; METHYL BETA CYCLODEXTRIN; NEUROTRANSMITTER RECEPTOR; SEROTONIN 1A RECEPTOR;

ALZHEIMER DISEASE; BIOSYNTHESIS; BRAIN LEVEL; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; CHOLESTEROL SYNTHESIS; DEGENERATIVE DISEASE; DISEASE SEVERITY; HUMAN; LIPID BRAIN LEVEL; MENTAL DEFICIENCY; MENTAL DISEASE; METABOLIC DISORDER; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SHORT SURVEY; SIGNAL TRANSDUCTION; SMITH LEMLI OPITZ SYNDROME;

BINDING SITES; BRAIN; CELL MEMBRANE; CHOLESTEROL; MEMBRANE LIPIDS; MEMBRANE PROTEINS; NERVOUS SYSTEM DISEASES; RECEPTOR, SEROTONIN, 5-HT1A; SIGNAL TRANSDUCTION;

EID: 33846638775     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.01.032     Document Type: Short Survey

References (65)

1. Wenk M.R. The emerging field of lipidomics. Nat. Rev. Drug Discov. 4 (2005) 594-610
2. Sastry P.S. Lipids of nervous tissue: composition and metabolism. Prog. Lipid Res. 24 (1985) 69-176
3. Burger K., Gimpl G., and Fahrenholz F. Regulation of receptor function by cholesterol. Cell. Mol. Life Sci. 57 (2000) 1577-1592
4. Pucadyil T.J., and Chattopadhyay A. Role of cholesterol in the function and organization of G-protein coupled receptors. Prog. Lipid Res. 45 (2006) 295-333
5. Papakostas G.I., Öngür D., Iosifescu D.V., Mischoulon D., and Fava M. Cholesterol in mood and anxiety disorders: review of the literature and new hypotheses. Eur. Neuropsychopharmacol. 14 (2004) 135-142
6. Harris J.S., Epps D.E., Davio S.R., and Kezdy F.J. Evidence for transbilayer, tail-to-tail cholesterol dimers in dipalmitoylglycerophosphocholine liposomes. Biochemistry 34 (1995) 3851-3857
7. Mukherjee S., and Chattopadhyay A. Membrane organization at low cholesterol concentrations: a study using 7-nitrobenz-2-oxa-1,3-diazol-4-yl-labeled cholesterol. Biochemistry 35 (1996) 1311-1322
8. Loura L.M., and Prieto M. Dehydroergosterol structural organization in aqueous medium and in a model system of membranes. Biophys. J. 72 (1997) 2226-2236
9. Tulenko T.N., Chen M., Mason P.E., and Mason R.P. Physical effects of cholesterol on arterial smooth muscle membranes: evidence of immiscible cholesterol domains and alterations in bilayer width during atherogenesis. J. Lipid Res. 39 (1998) 947-956
10. Rukmini R., Rawat S.S., Biswas S.C., and Chattopadhyay A. Cholesterol organization in membranes at low concentrations: effects of curvature stress and membrane thickness. Biophys. J. 81 (2001) 2122-2134
11. Mason R.P., Tulenko T.N., and Jacob R.F. Direct evidence for cholesterol crystalline domains in biological membranes: role in human pathobiology. Biochim. Biophys. Acta 1610 (2003) 198-207
12. Liscum L., and Underwood K.W. Intracellular cholesterol transport and compartmentation. J. Biol. Chem. 270 (1995) 15443-15446
13. Simons K., and Ikonen E. How cells handle cholesterol. Science 290 (2000) 1721-1725
14. Schroeder F., Woodford J.K., Kavecansky J., Wood W.G., and Joiner C. Cholesterol domains in biological membranes. Mol. Membr. Biol. 12 (1995) 113-119
15. Simons K., and Ikonen E. Functional rafts in cell membranes. Nature 387 (1997) 569-572
16. Xu X., and London E. The effect of sterol structure on membrane lipid domains reveals how cholesterol can induce lipid domain formation. Biochemistry 39 (2000) 843-849
17. Simons K., and van Meer G. Lipid sorting in epithelial cells. Biochemistry 27 (1988) 6197-6202
18. Simons K., and Toomre D. Lipid rafts and signal transduction. Nat. Rev. Mol. Cell Biol. 1 (2000) 31-39
19. Simons K., and Ehehalt R. Cholesterol, lipid rafts, and disease. J. Clin. Invest. 110 (2002) 597-603
20. T.J. Pucadyil, A. Chattopadhyay, (2007) Cholesterol: a potential therapeutic target in Leishmania infection?, Trends Parasitol., in press.
21. Dietschy J.M., and Turley S.D. Cholesterol metabolism in the brain. Curr. Opin. Lipidol. 12 (2001) 105-112
22. Mauch D.H., Nägler K., Schumacher S., Göritz C., Müller E.-C., Otto A., and Pfrieger F.W. CNS synaptogenesis promoted by glia-derived cholesterol. Science 294 (2001) 1354-1357
23. Wood W.G., Schroeder F., Avdulov N.A., Chochina S.V., and Igbavboa U. Recent advances in brain cholesterol dynamics: transport, domains, and Alzheimer's disease. Lipids 34 (1999) 225-234
24. Kabara J.J. A critical review of brain cholesterol metabolism. Prog. Brain Res. 40 (1973) 363-382
25. Turley S.D., Bruns D.K., and Dietschy J.M. Preferential utilization of newly synthesized cholesterol for brain growth in neonatal lambs. Am. J. Physiol. 274 (1998) E1099-E1105
26. Porter F.D. Malformation syndromes due to inborn errors of cholesterol synthesis. J. Clin. Invest. 110 (2002) 715-724
27. Vance J.E., Hayashi H., and Karten B. Cholesterol homeostasis in neurons and glial cells. Semin. Cell Dev. Biol. 16 (2005) 192-212
28. Waterham H.R., and Wanders R.J.A. Biochemical and genetic aspects of 7-dehydrocholesterol reductase and Smith-Lemli-Opitz Syndrome. Biochim. Biophys. Acta 1529 (2000) 340-356
29. Lee A.G. How lipids affect the activities of integral membrane proteins. Biochim. Biophys. Acta 1666 (2004) 62-87
30. Palsdottir H., and Hunte C. Lipids in membrane protein structures. Biochim. Biophys. Acta 1666 (2004) 2-18
31. Epand R.M., Maekawa S., Yip C.M., and Epand R.F. Protein-induced formation of cholesterol-rich domains. Biochemistry 40 (2001) 10514-10521
32. Fredriksson R., Lagerström M.C., Lundin L.-G., and Schiöth H.B. The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. Mol. Pharmacol. 63 (2003) 1256-1272
33. Pierce K.L., Premont R.T., and Lefkowitz R.J. Seven-transmembrane receptors. Nat. Rev. Mol. Cell Biol. 3 (2002) 639-650
34. Hopkins A.L., and Groom C.R. The druggable genome. Nat. Rev. Drug Discov. 1 (2002) 727-730
35. Karnik S.S., Gogonea S., Patil S., Saad Y., and Takezako T. Activation of G-protein coupled receptors: a common molecular mechanism. Trends Endocrinol. Metab. 14 (2003) 431-437
36. 1A receptor: a representative member of the serotonin receptor family. Cell. Mol. Neurobiol. 25 (2005) 553-580
37. Gingrich J.A., and Hen R. Dissecting the role of the serotonin system in neuropsychiatric disorders using knockout mice. Psychopharmacology 155 (2001) 1-10
38. 1A receptor knockout mouse as a genetic model of anxiety. Eur. J. Pharmacol. 463 (2003) 177-184
39. Gaspar P., Cases O., and Maroteaux L. The developmental role of serotonin: news from mouse molecular genetics. Nat. Rev. Neurosci. 4 (2003) 1002-1012
40. 1A receptor in neuronal cells during prolonged stress and degeneration. J. Neurochem. 66 (1996) 2361-2372
41. 1A receptors from bovine hippocampus. Biochim. Biophys. Acta 1663 (2004) 188-200
42. 1A receptor. Mol. Membr. Biol. 22 (2005) 241-249
43. 1A receptor. Biochem. Biophys. Res. Commun. 320 (2004) 557-562
44. 1A receptors. Biochem. Biophys. Res. Commun. 331 (2005) 422-427
45. 7(a)receptors. Eur. J. Pharmacol. 552 (2006) 1-10
46. Xiao Z.-L., Chen Q., Amaral J., Biancani P., Jensen R.T., and Behar J. CCK receptor dysfunction in muscle membranes from human gallbladders with cholesterol stones. Am. J. Physiol. 276 (1999) G1401-G1407
47. Xiao Z.-L., Chen Q., Amaral J., Biancani P., and Behar J. Defect of receptor-G protein coupling in human gallbladder with cholesterol stones. Am. J. Physiol. Gastrointest. Liver Physiol. 278 (2000) G251-G258
48. Steegmans P.H.A., Fekkes D., Hoes A.W., Bak A.A.A., van der Does E., and Grobbee D.E. Low serum cholesterol concentration and serotonin metabolism in men. Br. Med. J. 312 (1996) 221
49. Zureik M., Courbon D., and Ducimetière P. Serum cholesterol concentration and death from suicide in men: Paris prospective study I. Br. Med. J. 313 (1996) 649-651
50. Kirsch C., Eckert G.P., and Müller W.E. Statin effects on cholesterol micro-domains in brain plasma membranes. Biochem. Pharmacol. 65 (2003) 843-856
51. 1A receptor signaling in brains of suicide victims: involvement of adenylyl cyclase, phosphatidylinositol 3-kinase, Akt and mitogen-activated protein kinase. J. Neurochem. 87 (2003) 182-194
52. Beasley C.L., Honer W.G., von Bergmann K., Falkai P., Lütjohann D., and Bayer T.A. Reductions in cholesterol and synaptic markers in association cortex in mood disorders. Bipolar Disord. 7 (2005) 449-455
53. Wolozin B., Kellman W., Ruosseau P., Celesia G.G., and Siegel G. Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors. Arch. Neurol. 57 (2000) 1439-1443
54. Jick H., Zornberg G.L., Jick S.S., Seshadri S., and Drachman D.A. Statins and the risk of dementia. Lancet 356 (2000) 1627-1631
55. A currents by neurosteroids in dissociated hippocampal neurons. Neuropharmacology 37 (1998) 1103-1110
56. Smith D.W., Lemli L., and Opitz J.M. A newly recognized syndrome of multiple congenital anomalies. J. Pediatr. 64 (1964) 210-217
57. Irons M., Elias E.R., Salen G., Tint G.S., and Batta A.K. Defective cholesterol biosynthesis in Smith-Lemli-Opitz Syndrome. Lancet 341 (1993) 1414
58. Kandustch A.A., and Russell A.E. Preputial gland tumor sterols. A metabolic pathway from lanosterol to cholesterol. J. Biol. Chem. 235 (1960) 2256-2261
59. Kelley R.L., Roessler E., Hennekam R.C., Feldman G.L., Kosaki K., Jones M.C., Palumbos J.C., and Muenke M. Holoprosencephaly in RSH/Smith-Lemli-Opitz Syndrome: does abnormal cholesterol metabolism affect the function of Sonic Hedgehog?. Am. J. Med. Genet. 66 (1996) 478-484
60. Megha, Bakht O., and London E. Cholesterol precursors stabilize ordinary and ceramide-rich ordered lipid domains (lipid rafts) to different degrees: Implications for the bloch hypothesis and sterol biosynthesis disorders. J. Biol. Chem. 281 (2006) 21903-21913
61. Gondre-Lewis M.C., Petrache H.I., Wassif C.A., Harries D., Parsegian A., Porter F.D., and Loh Y.P. Abnormal sterols in cholesterol-deficiency diseases cause secretory granule malformation and decreased membrane curvature. J. Cell Sci. 119 (2006) 1876-1885
62. Tulenko T.N., Boeze-Battaglia K., Mason R.P., Tint G.S., Steiner R.D., Connor W.E., and Labelle E.F. A membrane defect in the pathogenesis of Smith-Lemli-Opitz Syndrome. J. Lipid Res. 47 (2006) 134-143
63. 1A receptors are increased in postmortem prefrontal cortex in schizophrenia. Brain Res. 708 (1996) 209-214
64. 1A receptors and dopamine in blood peripheral lymphocytes of major depression patients. Int. Immunopharmacol. 3 (2003) 1345-1352
65. 1A receptor gene polymorphism associated with major depression and suicide. J. Neurosci. 23 (2003) 8788-8799